Pre-admission use of sodium glucose transporter-2 inhibitor (SGLT-2i) may significantly improves Covid-19 outcomes in patients with diabetes: A systematic review …
Aims This study aims to examine the effectiveness of using sodium glucose transporter-2
inhibitor (SGLT-2i) before hospital admission on Covid-19 outcomes in diabetic patients …
inhibitor (SGLT-2i) before hospital admission on Covid-19 outcomes in diabetic patients …
[HTML][HTML] Risk phenotypes of diabetes and association with COVID-19 severity and death: an update of a living systematic review and meta-analysis
S Schlesinger, A Lang, N Christodoulou, P Linnerz… - Diabetologia, 2023 - Springer
Aims/hypothesis To provide a systematic overview of the current body of evidence on high-
risk phenotypes of diabetes associated with COVID-19 severity and death. Methods This is …
risk phenotypes of diabetes associated with COVID-19 severity and death. Methods This is …
[HTML][HTML] Effect of DPP4/CD26 expression on SARS‑CoV‑2 susceptibility, immune response, adenosine (derivatives m62A and CD) regulations on patients with …
J Du, J Fu, W Zhang, L Zhang… - International …, 2023 - spandidos-publications.com
The worldwide COVID‑19 pandemic was brought on by a new coronavirus (SARS Cov‑2). A
marker/receptor called Dipeptidyl peptidase 4/CD26 (DPP4/CD26) may be crucial in …
marker/receptor called Dipeptidyl peptidase 4/CD26 (DPP4/CD26) may be crucial in …
[HTML][HTML] Analysis of risk factors for COVID-19-related fatal outcome in 337991 patients with type 1 and type 2 diabetes mellitus in 2020–2022 years: Russian …
NG Mokrysheva, MV Shestakova, OK Vikulova… - Diabetes …, 2022 - dia-endojournals.ru
BACKGROUND: The coronavirus pandemic has had an extremely negative impact on the
patients with diabetes mellitus (DM both in terms of a more severe course of COVID-19 and …
patients with diabetes mellitus (DM both in terms of a more severe course of COVID-19 and …
[HTML][HTML] Mechanisms of endothelial activation, hypercoagulation and thrombosis in COVID-19: a link with diabetes mellitus
I Valencia, J Lumpuy-Castillo, G Magalhaes… - Cardiovascular …, 2024 - Springer
Early since the onset of the COVID-19 pandemic, the medical and scientific community were
aware of extra respiratory actions of SARS-CoV-2 infection. Endothelitis, hypercoagulation …
aware of extra respiratory actions of SARS-CoV-2 infection. Endothelitis, hypercoagulation …
[HTML][HTML] Анализ рисков летальности 337 991 пациента с сахарным диабетом, перенесшего COVID-19, за период 2020-2022 гг.: всероссийское …
НГ Мокрышева, МВ Шестакова, ОК Викулова… - Сахарный …, 2022 - cyberleninka.ru
Актуальность. Пандемия коронавирусной инфекции внесла крайне негативный вклад в
аспекты ведения пациентов с сахарным диабетом (СД), ставших «мишенью» вируса …
аспекты ведения пациентов с сахарным диабетом (СД), ставших «мишенью» вируса …
[HTML][HTML] Age and Comorbidities as Risk Factors for Severe COVID-19 in Mexico, before, during and after Massive Vaccination
L Domínguez-Ramírez, F Sosa-Jurado… - Vaccines, 2023 - mdpi.com
During 2020–2023, Mexico had a large COVID-19 emergency with> 331,000 adult deaths
and one of the highest excess mortalities worldwide. Age at COVID-19 death has been …
and one of the highest excess mortalities worldwide. Age at COVID-19 death has been …
[HTML][HTML] Diabetes Mellitus after SARS-CoV-2 Infection: An Epidemiological Review
Diabetes mellitus (DM) is among the major global public health issues. According to recent
projections, a continued rise in DM prevalence is expected in the following decades. The …
projections, a continued rise in DM prevalence is expected in the following decades. The …
Effects of the COVID-19 booster vaccine on glycemia and insulin resistance in people with type 1 diabetes: A prospective pilot study
M Zilbermint, M Motevalli, K Batty… - Diabetes research and …, 2023 - Elsevier
Aims Inflammation can trigger hyperglycemia in people with type 1 diabetes (T1D). Vaccines
purposefully intend to cause an acute immunogenic response, and booster vaccines may …
purposefully intend to cause an acute immunogenic response, and booster vaccines may …
[HTML][HTML] Insulin may increase disease severity and mortality of COVID-19 through Na+/H+ exchanger in patients with type 1 and type 2 diabetes mellitus
E Cure, M Cumhur Cure - Journal of Endocrinological Investigation, 2023 - Springer
The glucose-lowering treatment of patients with diabetes mellitus (DM) and severe novel
coronavirus disease 2019 (COVID-19) still remains a mystery. A recent meta-analysis and a …
coronavirus disease 2019 (COVID-19) still remains a mystery. A recent meta-analysis and a …